The development of autoantibodies after allogeneic stem cell transplantation is related with chronic graft-vs-host disease and immune recovery.

[1]  Stephanie J. Lee.  New approaches for preventing and treating chronic graft-versus-host disease. , 2005, Blood.

[2]  J. G. van den Tweel,et al.  Anti-CD20 monoclonal antibody treatment in 6 patients with therapy-refractory chronic graft-versus-host disease. , 2004, Blood.

[3]  Catherine J. Wu,et al.  Antibody responses to H-Y minor histocompatibility antigens correlate with chronic graft-versus-host disease and disease remission. , 2004, Blood.

[4]  M. Becker,et al.  Treatment of chronic graft-versus-host disease with anti-CD20 chimeric monoclonal antibody. , 2003, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[5]  R. Looney.  Treating human autoimmune disease by depleting B cells , 2002, Annals of the rheumatic diseases.

[6]  M. Leandro,et al.  Clinical outcome in 22 patients with rheumatoid arthritis treated with B lymphocyte depletion , 2002, Annals of the rheumatic diseases.

[7]  G. Remuzzi,et al.  Rituximab for idiopathic membranous nephropathy , 2002, The Lancet.

[8]  J. Kurtzberg,et al.  Combination treatment of bullous pemphigoid with anti-CD20 and anti-CD25 antibodies in a patient with chronic graft-versus-host disease , 2002, Bone Marrow Transplantation.

[9]  M. Fujimoto,et al.  CD19-dependent B lymphocyte signaling thresholds influence skin fibrosis and autoimmunity in the tight-skin mouse. , 2002, The Journal of clinical investigation.

[10]  J. Mary,et al.  Prolonged immune deficiency following allogeneic stem cell transplantation: risk factors and complications in adult patients , 2001, British journal of haematology.

[11]  A. Gratwohl,et al.  ‘Altered immunity syndrome’, a distinct entity in long-term bone marrow transplantation survivors? , 2001, Bone Marrow Transplantation.

[12]  S. Amadori,et al.  Rituximab chimeric anti-CD20 monoclonal antibody treatment for adults with chronic idiopathic thrombocytopenic purpura. , 2001, Blood.

[13]  M. Baccarani,et al.  Rituximab for myasthenia gravis developing after bone marrow transplant , 2000, Neurology.

[14]  G. Yanik,et al.  Anti-CD20 Chimeric Monoclonal Antibody Treatment of Refractory Immune-Mediated Thrombocytopenia in a Patient with Chronic Graft-versus-Host Disease , 2000, Annals of Internal Medicine.

[15]  A. Pestronk,et al.  IgM antibody-related polyneuropathies: B-cell depletion chemotherapy using Rituximab , 1999, Neurology.

[16]  M. Manns,et al.  Autoantibodies in human chronic graft-versus-host disease after hematopoietic cell transplantation. , 1999, Clinical immunology.

[17]  F. Ricci,et al.  Antibodies reactive with neutrophils following allogeneic haematopoietic stem cell transplantation , 1999, European journal of haematology.

[18]  Y. Shoenfeld,et al.  Autoimmune diseases and autoimmunity post-bone marrow transplantation , 1998, Bone Marrow Transplantation.

[19]  P. Veys,et al.  Anticardiolipin antibodies and thromboembolism after BMT , 1998, Bone Marrow Transplantation.

[20]  H. Einsele,et al.  CMV iNFECTION AFTER ALLOGENEIC BONE MARROW TRANSPLANTATION IS ASSOCIATED WITH THE OCCURRENCE OF VARIOUS AUTOANTIBODIES AND MONOCLONAL GAMMOPATHIES , 1996, British journal of haematology.

[21]  W. V. van Venrooij,et al.  Search for the antigen-specificity of homogeneous IgG components (H-IgG) after allogeneic bone marrow transplantation. , 1996, Bone marrow transplantation.

[22]  P. Ljungman,et al.  CD13-specific autoimmunity in cytomegalovirus-infected immunocompromised patients. , 1996, Transplantation.

[23]  P. Ljungman,et al.  Cytomegalovirus-induced CD13-specific autoimmunity--a possible cause of chronic graft-vs-host disease. , 1996, Transplantation.

[24]  T. Honjo,et al.  Involvement of B-1 cells in mucosal immunity and autoimmunity. , 1995, Immunology today.

[25]  W. Siegert,et al.  Antimitochondrial antibodies in patients with chronic graft-versus-host disease. , 1992, Bone marrow transplantation.

[26]  J. Węsierska‐Gądek,et al.  Autoantibodies in chronic GVHD: high prevalence of antinucleolar antibodies. , 1990, Bone marrow transplantation.

[27]  J. Whittaker,et al.  Autoantibody analysis in chronic graft-versus-host disease. , 1989, Bone marrow transplantation.

[28]  E. Gluckman,et al.  AUTOIMMUNITY AFTER ALLOGENEIC BONE MARROW TRANSPLANTATION A STUDY OF 53 LONG‐TERM‐SURVIVING PATIENTS , 1988, Transplantation.

[29]  E. Keystone,et al.  Autoantibody analysis of patients with graft versus host disease. , 1987, Journal of clinical & laboratory immunology.

[30]  E. Gluckman,et al.  Autoimmunity in 28 patients after allogeneic bone marrow transplantation: comparison with Sjögren syndrome and scleroderma. , 1987 .

[31]  K. Sullivan,et al.  Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. , 1980, The American journal of medicine.

[32]  P. Neiman,et al.  CLINICAL MANIFESTATIONS OF GRAFT‐VERSUS-HOST DISEASE IN HUMAN RECIPIENTS OF MARROW FROM HL‐A-MATCHED SIBLING DONOR,S , 1974, Transplantation.